Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Prestige Consumer Healthcare (PBH)
NYSE:PBH
RESEARCH TOOLSreports
Earnings Data
Report Date
May 01, 2025TBA Not Confirmed
Period Ending
2025 (Q4)Consensus EPS Forecast
1.3Last Year’s EPS
1.02Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 06, 2025
|% Change Since: 11.21%
|Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong quarterly performance with record sales and EPS, driven by international growth and improved financial health through debt reduction. However, challenges remain with declines in certain segments like Cough & Cold, supply chain constraints for Clear Eyes, and broader economic concerns such as tariffs and inflation.Company Guidance
During Prestige Consumer Healthcare's third quarter 2025 earnings call, the company reported record quarterly sales of $290 million, a 3% year-over-year increase, and a record quarterly EPS of $1.22, up 15% from the previous year. The call highlighted strong international growth, particularly for the Hydralyte brand, and broad-based growth across North American categories. The company also achieved a leverage ratio improvement to 2.5x and generated $184.9 million in free cash flow over the first nine months, anticipating a full-year free cash flow of $240 million or more. Looking ahead, Prestige Consumer forecasts full-year revenues between $1.128 billion and $1.132 billion, with an adjusted EPS of approximately $4.5, reflecting their successful debt reduction efforts and lower interest costs.Record Quarterly Sales and EPS
Net sales reached $290 million, increasing nearly 3% year-over-year, and earnings per share (EPS) increased by 15% to a record $1.22.
Strong International Growth
International segment sales grew approximately 8% excluding FX, driven by the Hydralyte brand.
Debt Reduction and Leverage Ratio Improvement
Reduced variable term loan debt balance to zero and improved leverage ratio to 2.5x.
Free Cash Flow Increase
Generated $184.9 million in free cash flow for the first nine months, up 5% year-over-year.
Strong Performance of GI Category
GI business represents nearly one-fifth of North American sales with solid mid-single-digit growth over the last three years.
---
PBH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PBH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 06, 2025 | $76.10 | $87.35 | +14.78% |
| Nov 07, 2024 | $77.64 | $80.09 | +3.16% |
| Aug 08, 2024 | $67.89 | $66.84 | -1.55% |
| May 14, 2024 | $71.47 | $66.46 | -7.01% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Prestige Consumer Healthcare (PBH) report earnings?
Prestige Consumer Healthcare (PBH) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
What is Prestige Consumer Healthcare (PBH) earnings time?
Prestige Consumer Healthcare (PBH) earnings time is at May 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PBH EPS forecast?
PBH EPS forecast for the fiscal quarter 2025 (Q4) is 1.3.
---